Immatics (IMTX) EBIT Margin (QoQ) (2019 - 2025)
Immatics (IMTX) EBIT Margin (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 98,066.00 |
| Sep 30, 2025 | 4,292.00 |
| Jun 30, 2025 | -73,380.00 |
| Mar 31, 2025 | -36,811.00 |
| Dec 31, 2024 | 10,606.00 |
| Sep 30, 2024 | 6,401.00 |
| Jun 30, 2024 | -8,563.00 |
| Mar 31, 2024 | 11,070.00 |
| Dec 31, 2023 | 35,494.00 |
| Sep 30, 2023 | -35,836.00 |
| Jun 30, 2023 | 12,219.00 |
| Mar 31, 2023 | -19,293.00 |
| Dec 31, 2022 | 9,366.00 |
| Sep 30, 2022 | -6,594.00 |
| Jun 30, 2022 | -15,435.00 |
| Mar 31, 2022 | 19,097.00 |
| Dec 31, 2021 | 31,605.00 |
| Sep 30, 2021 | 9,861.00 |
| Jun 30, 2021 | -19,878.00 |
| Mar 31, 2021 | -17,216.00 |